Popular Articles

A Selection Of Opinions And Editorials
Obama"s Health Cost Illusion Wall Street Journal

FDA Approves Generic Version Of Emergency Contraception Pills
FDA on Wednesday approved Watson Pharmaceuticals" generic version of the emergency contraceptive Plan B, the Wall Street Journal reports. The generic drug will be available without a prescription to women ages 18 and older on Aug. 24, when Duramed Pharmaceuticals" market exclusivity for Plan B expires (Kalish, Wall Street Journal, 6/25). The generic version will be available to women ages 17 and younger with a prescription, according to an FDA press release (FDA Web site, 6/24). Watson will market the generic version under the name Next Choice (AP/Washington Post, 6/24).A one-time use pack of the brand-name product, Plan B, currently costs $49.99 through the online retailer DrugStore.com. According to Bloomberg, generic drugs usually cost 30% to 80% less than brand-name versions (Larkin, Bloomberg, 6/24).
News of the day
Total Artificial Heart Bridges People Rejecting Donor Hearts To 2nd Transplant
During 2008, 10% of people who were implanted with the SynCardia temporary CardioWest™ Total Artificial Heart received the device because they were suffering from rejection of their donor heart transplant.
Diagnostics

Schizophrenia: A Genetic Basis

Schizophrenia is a severely debilitating psychiatric disease that is thought to have its roots in the development of the nervous system; however, major breakthroughs linking its genetics to diagnosis, prognosis and treatment are still unrealized. Jill Morris, PhD assistant professor of Pediatrics at Northwestern University"s Feinberg School of Medicine and a researcher in the Human Molecular Genetics Program of Children"s Memorial Research Center studies a gene that is involved in susceptibility to schizophrenia, Disc1 (Disrupted-In-Schizophrenia 1). Two recent publications by Morris and colleagues focus on the role of Disc1 in development, particularly the migration of cells to their proper location in the brain and subsequent differentiation into their intended fate. During development, cells need to properly migrate to their final destination in order to develop into the appropriate cell-type, integrate into the corresponding network of cells and function properly. Disruption of cell migration can lead to inappropriate cell development and function, resulting in disease. The first paper, published in the July 2009 online issue of the journal Development, followed the role of Disc1 in cranial neural crest (CNC) cells, which are multi-potent cells that give rise to multiple cell types including craniofacial cartilage and the peripheral nervous system during development. They also are similar to neurons in their high mobility, response to signals and cellular origin. The Morris laboratory determined that Disc1 regulates two stem cell maintenance factors that have many functions in CNC cells, including the maintenance of precursor pools, timing of migration onset and the induction of cell differentiation. The authors showed that Disc1 disruption results in increased expression of these factors, leading to hindered cell migration and a change in cell fate. "This research indicates that Disc1 may be involved in regulating stem cells and their fate," says Morris. The second paper, published in the June 2009 online issue of Human Molecular Genetics, studied the hippocampus, a brain area that is involved in learning and memory, and is also associated with the pathology of schizophrenia. Disc1 is highly expressed in the hippocampus, particularly the dentate gyrus, which is considered the gateway to the hippocampus. In this study, the authors decreased Disc1 expression using RNA interference in the developing mouse hippocampus. The loss of Disc1 resulted in hindered migration of dentate gyrus granule cells to their proper location in the brain. "Improper migration of hippocampal neurons may result in altered connectivity in the brain," says Morris. Co-authors on these publications are (Development): Catherine Drerup, PhD, Heather Wiora and Jacek Topczewski, PhD; and (Human Molecular Genetics): Kate Meyer. Drerup is a former graduate student and Meyer a current graduate student, both in the Morris laboratory. Funding was provided by the McKnight Brain Disorders Award; the National Alliance for Research on Schizophrenia and Depression; the National Institute of Mental Health; and the Illinois Department of Public Aid. Peggy Jones Children"s Memorial Hospital


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):